Breast Neoplasms Clinical Trials in Maastricht, Limburg
2 recruitingMaastricht, Limburg, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Not Applicable
Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer
Breast CancerBreast Neoplasms
Maastricht University Medical Center11 enrolled1 locationNCT06266312